Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, indicating a new release/version of the page. This is reflected in the revision history as the most recent change.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2. This indicates a newer version of the page has been published.SummaryDifference0.0%

- Check34 days agoChange DetectedRecruitment is closed for the study. The latest revision tag is v3.6.0, replacing v3.5.5.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page's revision tag has changed from v3.5.4 to v3.5.5, signaling a new version of the record display. This likely reflects minor updates or fixes to the page's metadata or UI without changing the underlying study data.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a new release of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check83 days agoChange DetectedThe ClinicalTrials.gov page footer/version indicator has been updated from “v3.5.2” to “v3.5.3,” reflecting a software release rather than a change to the study history details.SummaryDifference0.0%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.